Correlation Between Valic Company and Sarofim Equity

Can any of the company-specific risk be diversified away by investing in both Valic Company and Sarofim Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valic Company and Sarofim Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Valic Company I and Sarofim Equity, you can compare the effects of market volatilities on Valic Company and Sarofim Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valic Company with a short position of Sarofim Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valic Company and Sarofim Equity.

Diversification Opportunities for Valic Company and Sarofim Equity

0.87

Correlation Coefficient

Valic Company  Sarofim Equity

Very poor diversification

The 3 months correlation between Valic and Sarofim is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Valic Company I and Sarofim Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarofim Equity and Valic Company is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valic Company I are associated (or correlated) with Sarofim Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarofim Equity has no effect on the direction of Valic Company i.e., Valic Company and Sarofim Equity go up and down completely randomly.

Pair Corralation between Valic Company and Sarofim Equity

Assuming the 90 days horizon Valic Company I is expected to under-perform the Sarofim Equity. In addition to that, Valic Company is 2.26 times more volatile than Sarofim Equity. It trades about -0.01 of its total potential returns per unit of risk. Sarofim Equity is currently generating about 0.25 per unit of volatility. If you would invest  1,685  in Sarofim Equity on September 19, 2024 and sell it today you would earn a total of  33.00  from holding Sarofim Equity or generate 1.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Valic Company I  vs.  Sarofim Equity

Valic Company I

Risk-Adjusted Performance

2 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Valic Company I are ranked lower than 2 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong fundamental indicators, Valic Company is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sarofim Equity

Risk-Adjusted Performance

3 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Sarofim Equity are ranked lower than 3 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong primary indicators, Sarofim Equity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Valic Company and Sarofim Equity

The main advantage of trading using opposite Valic Company and Sarofim Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valic Company position performs unexpectedly, Sarofim Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarofim Equity will offset losses from the drop in Sarofim Equity's long position.

The idea behind Valic Company I and Sarofim Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.